Sequencing-based diagnostics for pediatric genetic diseases: progress and potential
- 17 August 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 16 (9) , 987-999
Abstract
Introduction: The last two decades have witnessed revolutionary changes in clinical diagnostics, fueled by the Human Genome Project and advances in high throughput, Next Generation Sequencing (NGS). We review the current state of sequencing-based pediatric diagnostics, associated challenges, and future prospects. Areas covered: We present an overview of genetic disease in children, review the technical aspects of Next Generation Sequencing and the strategies to make molecular diagnoses for children with genetic disease. We discuss the challenges of genomic sequencing including incomplete current knowledge of variants, lack of data about certain genomic regions, mosaicism, and the presence of regions with high homology. Expert commentary: NGS has been a transformative technology and the gap between the research and clinical communities has never been so narrow. Therapeutic interventions are emerging based on genomic findings and the applications of NGS are progressing to prenatal genetics, epigenomics and transcriptomics.Keywords
Funding Information
- National Human Genome Research Institute (U01-HG006546)
- National Institute of Diabetes and Digestive and Kidney Diseases (1 R01KD090045-01, U01 DK062481)
This publication has 101 references indexed in Scilit:
- Clinical Diagnosis by Whole-Genome Sequencing of a Prenatal SampleNew England Journal of Medicine, 2012
- The Pediatric Cancer Genome ProjectNature Genetics, 2012
- A novel retinoblastoma therapy from genomic and epigenetic analysesNature, 2012
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTDNeuron, 2011
- Next-Generation Sequencing Strategies Enable Routine Detection of Balanced Chromosome Rearrangements for Clinical Diagnostics and Genetic ResearchThe American Journal of Human Genetics, 2011
- A map of human genome variation from population-scale sequencingNature, 2010
- Target-enrichment strategies for next-generation sequencingNature Methods, 2010
- Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencingNature Biotechnology, 2009
- Next-generation DNA sequencingNature Biotechnology, 2008
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences of the United States of America, 2004